This platform is currently totally free and created by doctors. 🩺

RxIndia

Loading clinical data...

The most trusted clinical drug reference for Indian healthcare professionals. Providing evidence-based monographs, dosage protocols, and expert guidelines to empower better clinical decisions.

Resources

Full Drug Index
Clinical Guidelines
Classifications
Specialties

Weekly Updates

Stay updated with the latest FDA approvals, drug alerts, and clinical practices.

Verified Clinical Information

"This platform is a clinical reference tool for educational purposes only. It is not a substitute for professional medical judgment, diagnosis, or treatment. Always seek the advice of a qualified physician."

A Medical Intelligence Initiative

About Contact Privacy Terms

Developeredonesolutions

HomeDrug Index

The Drug Registry

Found 5 drugs.

Abciximab

Glycoprotein IIb/IIIa receptor antagonist

PCIspecific agent: Only effective when PCI is performed; not useful in conservative medical management of ACS Readministration caution: Avoid repeat...

View Details

Clopidogrel

P2Y12 ADP receptor inhibitor (Thienopyridine)

1. PPI selection matters: Always avoid omeprazole and esomeprazole with clopidogrel due to CYP2C19 interaction. Prefer pantoprazole or rabeprazole — t...

View Details

Eptifibatide

Glycoprotein IIb/IIIa Receptor Inhibitor

Triple therapy essential: Always coadminister with aspirin and unfractionated heparin in ACS/PCI — improves outcomes significantly in highrisk patient...

View Details

Ticagrelor

P2Y12 Receptor Antagonist (Reversible, Direct-acting)

1. Superior to clopidogrel in ACS — PLATO trial demonstrated significant reduction in cardiovascular death, MI, and stroke compared to clopidogrel; pr...

View Details

Tirofiban

Glycoprotein IIb/IIIa receptor antagonist

1. Always reduce maintenance infusion dose in renal impairment — even moderate CKD (CrCl 30–59) requires reduction to 0.1 mcg/kg/min 2. Monitor plate...

View Details

All 5 drugs shown